Search research articles
Contact Us
Filters
Showing results (191-200 of 208) with videos related to
Page
of 21
Sort By:
Physical Chemistry Chemical Physics : PCCP
|
September 4, 2014
Dielectric, calorimetric and mesophase properties of 1''-(2',4-difluorobiphenyl-4'-yloxy)-9''-(4-cyanobiphenyl-4'-yloxy) nonane: an odd liquid crystal dimer with a monotropic mesophase having the characteristics of a twist-bend nematic phase
N Sebastián, D O López, B Robles-Hernández, et al.
The New England Journal of Medicine
|
October 10, 1996
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team
D A Katzenstein, S M Hammer, M D Hughes, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 22, 2000
Enhanced cAMP-induced nitric oxide-dependent coronary dilation during myocardial stunning in conscious pigs
R K Kudej, X P Zhang, B Ghaleh, et al.
The Journal of Infectious Diseases
|
July 1, 1995
Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs
M M Lederman, J B Jackson, B L Kroner, et al.
The New England Journal of Medicine
|
May 22, 1997
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group
J M Jacobson, J S Greenspan, J Spritzler, et al.
Annals of Internal Medicine
|
December 4, 2001
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320
L M Demeter, M D Hughes, R W Coombs, et al.
AIDS Research and Human Retroviruses
|
August 24, 2000
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team
A Wiznia, K Stanley, P Krogstad, et al.
Transfusion
|
October 13, 1998
Interagency Genome Amplification Testing Task Force: preliminary report
J McCullough, C Bianco, M Busch, et al.
The Journal of Infectious Diseases
|
March 14, 1998
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team
J L Lathey, M D Hughes, S A Fiscus, et al.
AIDS (London, England)
|
April 10, 1999
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)
P Musoke, L A Guay, D Bagenda, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 208) with videos related to
Sort By:
Page
of 21
Physical Chemistry Chemical Physics : PCCP
|
September 4, 2014
Dielectric, calorimetric and mesophase properties of 1''-(2',4-difluorobiphenyl-4'-yloxy)-9''-(4-cyanobiphenyl-4'-yloxy) nonane: an odd liquid crystal dimer with a monotropic mesophase having the characteristics of a twist-bend nematic phase
N Sebastián, D O López, B Robles-Hernández, et al.
The New England Journal of Medicine
|
October 10, 1996
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team
D A Katzenstein, S M Hammer, M D Hughes, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 22, 2000
Enhanced cAMP-induced nitric oxide-dependent coronary dilation during myocardial stunning in conscious pigs
R K Kudej, X P Zhang, B Ghaleh, et al.
The Journal of Infectious Diseases
|
July 1, 1995
Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs
M M Lederman, J B Jackson, B L Kroner, et al.
The New England Journal of Medicine
|
May 22, 1997
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group
J M Jacobson, J S Greenspan, J Spritzler, et al.
Annals of Internal Medicine
|
December 4, 2001
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320
L M Demeter, M D Hughes, R W Coombs, et al.
AIDS Research and Human Retroviruses
|
August 24, 2000
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team
A Wiznia, K Stanley, P Krogstad, et al.
Transfusion
|
October 13, 1998
Interagency Genome Amplification Testing Task Force: preliminary report
J McCullough, C Bianco, M Busch, et al.
The Journal of Infectious Diseases
|
March 14, 1998
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team
J L Lathey, M D Hughes, S A Fiscus, et al.
AIDS (London, England)
|
April 10, 1999
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)
P Musoke, L A Guay, D Bagenda, et al.
Page
of 21